Navigation Links
DuPont Focused on Meeting Global Demands for Greater Safety & Protection
Date:9/18/2007

SAN FRANCISCO, Sept. 18 /PRNewswire-FirstCall/ -- DuPont Group Vice President Mark P. Vergnano told investment analysts at the Bank of America Securities 37th Annual Investor Conference today that the Safety & Protection business segment is focused on meeting growing global demands for products and services that protect lives, structures, critical processes and the environment.

"DuPont is uniquely positioned to deliver innovations for safety and security at home, at work and in the world around us," Vergnano said. "We have broadened the definition of our addressable markets and are advancing a rich pipeline of science-based solutions for those markets. The business opportunities for DuPont in this segment are exceptional."

DuPont Safety & Protection is focused on four key value propositions that guide its priorities for innovation and investment:

-- Protecting lives - Addressing challenges to human health and safety,

including biosecurity, with products that include protective apparel,

materials and equipment for soldiers, law enforcement personnel and

emergency responders.

-- Safe and durable buildings - Delivering innovative building solutions

that integrate safety, durability, beauty and energy efficiency in

commercial and residential construction.

-- Protecting critical processes - Providing offerings that improve

critical performance systems; mitigate and detect microbial

contamination in food and biotechnology operations; and employ

filtration technologies that reduce contamination in refinery and

semiconductor markets.

-- Protecting the environment - Delivering technologies and services that

provide cleaner air, fuel and water for industry.

"We are leveraging our globally recognized branded products -- DuPont(TM) Kevlar(R), Nomex(R) and Tyvek(R) -- around the world, while accelerating the introduction of new products that protect lives and property," Vergnano said.

This year's new product launches include Protera(R) protective clothing, Kevlar(R) New Fiber Technology, Tyvek(R) Silver, Energain(R) mass storage materials, avian influenza biosecurity kits and Hybrid Membrane Technology for filtration applications.

DuPont Safety & Protection is capitalizing on over 200 years of DuPont experience as one of the safest companies in the world; recognized excellence in science and technology; and in-depth knowledge of key markets.

Presentation slides from today's meeting are available in the Investor Center at http://www.dupont.com.

DuPont (NYSE: DD) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

9/18/07

The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), and Kevlar(R), Nomex(R), Tyvek(R) and Energain(R) are registered trademarks or trademarks of DuPont or its affiliates.

For bio/photo of Mark Vergnano: http://www2.dupont.com/Our_Company/en_US/executives/vergnano.html


'/>"/>
SOURCE DuPont
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Focused Treatment For Childhood Cancer
2. DNA transcription to be focused
3. Fibroid Symptoms in Women can Be Relieved by Focused Ultrasound
4. Cognitive Skills Focused Curriculum may Lessen Kids Behavioural Problems
5. Scotland lags far behind in meeting the demand of prostate cancer treatment
6. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
7. Meeting To Discuss Issue Of Personal Health Records
8. Virtual Meeting Place Unites Patients with Brain Tumors and Neurosurgical Disorders
9. Meeting to tackle Chikungunya
10. Review Meeting on Avian Flu
11. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: